, Tracking Stock Market Picks
Enter Symbol:
Santarus, Inc. (SNTS) [hlAlert]

up 1,199.18 %

Santarus, Inc. (SNTS) rated Buy by Merriman Curhan Ford

Posted on: Thursday,  Jun 5, 2008  8:25 AM ET by Merriman Curhan Ford

Merriman Curhan Ford rated Buy Santarus, Inc. (NASDAQ: SNTS) on 06/05/2008, when the stock price was $2.46. Since
then, Santarus, Inc. has gained 1199.19% as of 12/31/2014's recent price of $31.96.
If you would have followed this Merriman Curhan Ford's recommendation on SNTS, you would have gained 1199.18% of your investment in 2400 days.

Santarus Inc is a specialty pharmaceutical company focused on acquiring, developing and commercializing proprietary products for the prevention and treatment of gastrointestinal diseases and disorders.

We occupy a unique niche among our investment banking peers: we offer our clients both traditional sell-side equity research and primary market research, and we focus on high-potential sectors such as CleanTech, Consumer/Internet/Media, Health Care and Tech/Telecom. Our institutional and corporate clients get the best of both worlds: expertise from our analysts and access to experts through our Panel Intelligence platform.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/5/2008 8:25 AM Buy
as of 12/24/2008
1 Week down  -1.06 %
1 Month up  44.53 %
3 Months up  13.49 %
1 YTD up  17.83 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy